June 2017 FDA Recall Drug by Bausch & Lomb, Inc.
D-0899-2017 - CGMP Deviations

This Class II drug recall was voluntarily initiated by Bausch & Lomb, Inc. on June 6, 2017 for the product Drug. The FDA reported the reason for recall as cgmp deviations. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0899-2017

Reason for Recall
CGMP Deviations: Possibility of the presence of microbial contamination in the water used to manufacture this product lot.
Initiated
06-06-2017
Reported
06-21-2017
Quantity
44,520 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Nationwide in the USA
NasalCrom (cromolyn sodium) Nasal Spray, USP, 5.2 mg per spray, 200 metered sprays, 0.88 FL OZ (26 mL) metered spray pump bottle, Distributed by: Medtech Products, Inc., Tarrytown, NY 10591, UPC 8 148332 01101 7.

Batch or Lot Expiration Information

Lot# Lot: 253211, Exp 12/18